
Historique
1992 : Faisabilité du radiomarquage des leucocytes au FDG
Osman S, Danpure HJ : The use of 2-[18F]fluoro-2-deoxy-D-glucose as a potential in vitro
agent for labelling human granulocytes for clinical studiesby positron emission tomography. Int J
Rad Appl Instrum B 19 : 183-190,1992
2002 : Biodistribution et Dosimétrie
Forstrom LA, Dunn WL, Mullan BP, Hung JC, Lowe VJ, Thorson LM : Biodistribution and
dosimetry of [(18)F]fluorodeoxygluxose labelled leukocytes in normal human subjects. Nucl Med
Commun 23 : 721-725, 2002.
2005 : Comparaison FDG / FDG-LKC
Pellegrino D, Bonab AA, Dragotakes SC, Pitman JT, Mariani G, Carter EA : Inflammation and
infection : imaging properties of FDG-labeled white blood cells versus 18F-FDG. J Nucl Med 46
: 1522-1530, 2005
2006 : Comparaison
111
In-oxine / FDG-LKC
Rini JN, Bhargava KK, TRonco GG, Singer C, Caprioli R, Marwin SE, Richardson HL, Nichols
KJ, Pugliese PV, Palestro CJ : PET with 18F-FDG labeled leukocytes versus scintigraphy with
111In-oxine-labeled leukocytes for detection of infection. Radiology 238 : 978-987, 2006
2006 : Première série de 21 patients
Dumarey N, Egrise D, Blocklet D, Stallenberg B, Remmelink M, del Marmol V, Van Simaeys G,
Jacobs F, Goldman S : Imaging infection with FDGlabeled leukocyte PET/CT : initial experience
in 21 patients. J Nucl Med 47 : 625-632, 2006